Insmed Incorporated: FDA Approves BRINSUPRI (brensocatib) as the First and Only Treatment for Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease
Insmed Incorporated: FDA Approves BRINSUPRI (brensocatib) as the Fi…
7 months ago
finanznachrichten.de
Insmed soars on positive lung drug study results
1:46
Insmed soars on positive lung drug study results
Sep 5, 2017
CNBC
Insmed: How We Approach Gene Therapy
5:25
Insmed: How We Approach Gene Therapy
395 viewsFeb 4, 2025
YouTubeInsmed
Latest read on first-in-disease therapy from Insmed CEO Will Lewis
5:01
Latest read on first-in-disease therapy from Insmed CEO Will Lewis
4 months ago
MSNCNBC
Insmed CEO on what’s next for company after FDA greenlights lung disease drug
5:06
Insmed CEO on what’s next for company after FDA greenlights lu…
7 months ago
MSNCNBC
$INSM trading near record highs as the FDA greenlights a first of its kind treatment for a chronic lung disease CEO Will Lewis shares what that means for his company, and what's next on the roadmap | CNBC Fast Money
4:13
$INSM trading near record highs as the FDA greenlights a first of its ki…
1.7K views7 months ago
FacebookCNBC Fast Money
Insmed Incorporated (INSM) Enters 2026 With Momentum
Insmed Incorporated (INSM) Enters 2026 With Momentum
1 week ago
YahooBob Karr
Insmed Says Brensocatib Showed Consistent Efficacy in Non-Cystic …
9 months ago
marketscreener.com
Insmed Incorporated(NasdaqGS: INSM) added to NASDAQ-100 Index
2 months ago
marketscreener.com
1:44
Insmed stock blasts off over lung condition study results
May 28, 2024
Yahoo
3:45
$INSM more than doubling today on positive phase three lung drug tria…
2K viewsMay 28, 2024
FacebookCNBC Fast Money
When Will Insmed Incorporated (NASDAQ:INSM) Become Profitabl…
1 month ago
YahooSimply Wall St
5:15
Insmed CEO on lung disease treatment and path forward
May 28, 2024
CNBC
Top 5% Biotech Hits Record On Its 'Skeleton Key' Approval
7 months ago
investors.com
3:09
Our sponsor Insmed is raising awareness for chronic inflammato…
331.5K views4 months ago
FacebookGood Morning America
Bridgewater firm's stock jumps after FDA approves its new lung diseas…
7 months ago
mycentraljersey.com
5:30
Insmed is nearly on pace with Palantir for gains this year - nearl…
2.2K views4 months ago
FacebookCNBC Fast Money
Stocks To Watch: Insmed Sees RS Rating Jump To 93
9 months ago
investors.com
Insmed TV Spot, 'Loud'
4 months ago
iSpot.tv
0:42
Learn why Kathryn is passionate about working in the rare disease …
Feb 21, 2024
linkedin.com
6:37
Chart of the Day: Insmed
May 28, 2024
CNBC
30:25
Insmed’s ASCEND Study and INS1201, an Investigational Gene …
46 views1 month ago
YouTubeMDA
Insmed Incorporated : La valeur du jour à Wall Street Insmed flambe a…
9 months ago
zonebourse.com
26:49
Insmed's ASCEND Study and INS1201, an Investigational Gene …
165 views3 months ago
YouTubeCureDuchenneMD
Transcript : Insmed Incorporated, Q1 2025 Earnings Call, May 08, 2025
10 months ago
zonebourse.com
Should I Buy Insmed Incorporated (INSM)?
Sep 16, 2020
insidermonkey.com
Insmed Incorporated | LinkedIn
8 months ago
linkedin.com
1:01:44
NTM Lung Disease Webinar
338 viewsNov 2, 2020
YouTubeGlobal Genes - Allies in Rare Disease
2:22
Arikayce_HCP_MOA
6.8K viewsOct 26, 2018
VimeoINSMED
Why This Top Biotech Just Screamed To A 25-Year High
4 months ago
investors.com
See more videos
Static thumbnail place holder